glp-1 receptor agonists and cancer risk in adults with obesity Glucagon-like peptide 1 risk: advancing precision medicine through mechanistic understanding and clinical evidence GLP-1 Receptor Agonists in Breast

Chen K, Jin HJ, Wu ZH, et al

Certain polyphenol-rich foods have shown promise in preliminary research: Green tea contains catechins that may influence metabolic pathways Berries (blueberries, strawberries, blackberries) provide anthocyanins with potential metabolic benefits Turmeric (curcumin) has been investigated for effects on glucose metabolism It is crucial to emphasise that while these foods may support natural GLP-1 production, there is no official link established between consuming specific foods and clinically significant increases in GLP-1 comparable to pharmaceutical treatments

This analysis examines CMSs Medicare Part D claims data from 2019 to 2024 to document the increase in the number of beneficiaries being treated with GLP-1 drugs and the growth in Medicare spending and claims for GLP-1s

CNBC is now accepting nominations for the 2023 Disruptor 50 list our 11th annual look at the most innovative venture-backed companies

Abnormal circulating levels of matrix metalloproteinases and their inhibitors in diabetes mellitus

Metformin is the most widely prescribed drug to treat hyperglycaemia in patients with type 2 diabetes